INTRODUCING
THE WHIZZ
A smart spacer system that improves respiratory care by ensuring medication reaches the lungs where it’s needed most.
- Optimises medication delivery
- Tracks intake data for better treatment insights
- Paired with a mobile app to manage regimens
- Gamification to encourage correct use and adherence
Approved & Certified By
IMPROVING ASTHMA CONTROL
Correct Technique Every Time
Correct Technique Every Time
Correct Technique Every Time
LED indicators provide instant feedback to patients and healthcare providers on each breath.
🟢 Green: Inhalation within the optimal range for lung delivery
🔴 Red: Inhalation outside the range, indicating throat deposition
Encourage Daily Adherence
Correct Technique Every Time
Correct Technique Every Time
Customisable reminders prompt patients to take medication at the right time, simplifying long-term, daily treatment routines.
Actionable Reports
Actionable Reports
Actionable Reports
Our mobile app automatically records and summarizes:
📊 Medication adherence
🌬️ Inhalation technique
⚠️ Symptoms and triggers
Built-In Rewards
Actionable Reports
Actionable Reports
Child-friendly rewards system encourages accurate and consistent use.
🎯 Progress tracked automatically
🏆 Goals, rewards, and difficulty levels fully customisable
👨👩👧 Empowers children and parents to stay engaged
Over 50% of patients with asthma or COPD use their inhalers incorrectly¹, resulting in suboptimal drug delivery to the lungs and increased oropharyngeal deposition. Large systematic reviews report inhaler technique error rates ranging from 50–80% of users, depending on device type and population studied.²
Incorrect inhaler technique is associated with reduced treatment effectiveness and poorer disease control, and may increase local side effects due to medication deposited in the throat.³
Children and older adults are especially vulnerable to inhaler errors because of coordination difficulties, reduced inspiratory flow, or cognitive and physical limitations.³ Poor inhaler technique frequently coexists with suboptimal adherence, including missed or forgotten doses.⁴
Inhaler misuse and poor adherence are linked to worse symptom control, more frequent exacerbations, increased emergency visits, and higher rates of hospitalisation, contributing to substantially greater healthcare utilisation and costs.³
Asthma
GLOBAL
- 260+ million people affected worldwide¹
- Most common chronic disease in children¹
- Leading cause of school absenteeism²
SINGAPORE
- ~1 in 5 children affected (~20%)²
- Among the highest childhood asthma prevalence rates globally³
Chronic Obstructive Pulmonary Disease (COPD)
GLOBAL
- 210 million people living with COPD (2021)⁴
- 3.7M deaths annually⁴
- Leading cause of death & disability worldwide*
- Risk increases significantly after age 60⁴
SINGAPORE
- ~2.3% of adults (~87,800 people) affected**
- Top-10 cause of death & hospitalisation^
- Risk rises sharply with age**
Our Partners
